Detection of adverse reactions involves preclinical studies in animals, clinical trials in humans, and post-marketing surveillance. Pharmacovigilance systems play a crucial role in monitoring and evaluating adverse reactions after a product is on the market, providing data for regulatory authorities to ensure public safety.
